NRX Pharmaceuticals NRXP Growth Metrics (2018-2026)

NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

NRX Pharmaceuticals Quarterly Growth Metrics

Periods 34 quarters
Latest Jun 2026

NRX Pharmaceuticals reported asset growth of 606.08% for the quarter ended Jun 2026. These growth metrics cover 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
650.20%1,012.79%623.34%74.87%-45.14%-21.12%-50.05%-38.92%-47.19%-71.66%-82.61%-73.43%-65.96%-50.09%100.37%-8.09%236.08%254.86%56.82%606.08%
Assets Growth (3y)
-13.49%-22.68%-15.28%-13.49%-15.87%-6.98%51.43%46.68%29.53%35.49%-14.35%-34.28%-53.80%-51.86%-44.16%-46.97%-15.47%-20.53%-18.24%19.92%
Assets Growth (5y)
-17.98%-20.72%-22.25%-28.44%-36.49%-44.46%-36.28%-36.04%-35.25%3.89%-5.07%19.98%34.52%14.58%12.99%
Assets (QoQ)
143.98%-27.67%33.22%-25.61%-23.46%4.00%-15.63%-9.05%-33.82%-44.20%-48.22%38.97%-15.24%-18.18%107.89%-36.26%209.96%-13.60%-8.13%186.99%
Capital Expenditures Growth (1y)Capex Growth (1y)
25.00%33.33%-166.67%-60.00%0.00%
Capital Expenditures (QoQ)Capex (QoQ)
0.00%66.67%-120.00%500.00%-150.00%200.00%-150.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
2,919.48%1,385.33%202.93%83.38%-53.07%-27.35%-58.94%-39.02%-51.22%-77.09%-92.01%-87.31%-81.51%-68.60%320.62%53.16%337.42%440.33%21.00%817.53%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
696.03%1,255.70%2,706.84%2,501.66%354.57%183.79%489.01%146.78%90.50%35.22%-53.68%-47.84%-65.15%-62.61%-48.32%-50.88%-26.66%-27.01%-25.91%21.28%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
113.76%128.12%154.71%158.52%233.85%273.36%323.54%53.32%10.46%133.01%23.92%41.09%33.21%-12.74%14.81%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
190.47%-29.01%45.63%-38.94%-25.66%9.89%-17.69%-9.31%-40.53%-48.38%-71.29%44.05%-13.37%-12.33%284.48%-47.55%147.42%8.29%-13.90%297.74%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-101.31%0.00%-25.00%-33.33%166.67%60.00%0.00%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
81.93%-25.99%-26.00%-95.30%-26.00%27.78%-26.13%25.99%-700.10%-530.80%-276.22%-600.68%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
14.87%-16.79%-59.63%60.60%-196.20%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-33.33%0.00%-66.67%120.00%-500.00%150.00%-200.00%150.00%90.28%14.46%-221.13%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-963.17%-2,673.50%-244.28%-29.81%47.84%26.26%41.34%47.18%27.16%61.63%39.71%67.20%49.47%34.27%5.20%-57.22%-25.41%-76.93%-23.56%-120.95%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-226.69%-334.23%-392.94%-216.62%-330.28%-128.84%-59.25%-98.73%-6.78%39.19%42.32%42.92%30.53%35.18%22.72%23.58%10.95%-4.44%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-127.73%-98.45%-65.27%-69.96%-113.23%-51.59%-114.61%-43.94%-20.68%-55.62%-7.36%4.82%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-5.44%6.11%7.98%-42.50%57.64%-32.75%26.80%-28.30%41.58%30.06%-15.01%30.21%9.99%9.02%-65.87%-15.75%28.20%-28.35%-15.84%-106.98%
EBITDA Margin Growth (5y)
4,064.93M
EBITDA Margin (QoQ)
0.12M0.00M-0.02M
EBIT Growth (1y)
-290.33%-17.40%38.66%43.92%54.52%81.33%75.50%14.71%36.46%55.44%-55.91%13.90%47.97%44.80%35.86%47.09%-33.16%-90.13%-23.26%-74.40%
EBIT Growth (3y)
-350.22%-358.27%-279.43%-268.08%-272.73%-218.29%-331.09%-4.09%53.95%38.36%25.60%46.83%64.19%37.43%27.03%23.93%22.38%-7.22%7.38%
EBIT Growth (5y)
-136.21%-82.05%-97.60%-92.41%-105.62%-109.25%-75.16%-66.34%-100.31%-106.54%4.81%36.59%28.63%17.59%
EBIT Margin Growth (1y)
EBIT Margin Growth (3y)
EBIT Margin Growth (5y)
91.95M4,065.06M2,909.62M
EBIT Margin (QoQ)
0.12M0.00M-0.02M
EBIT (QoQ)
-17.42%-163.57%70.35%38.87%4.78%-8.17%61.09%-112.84%29.07%24.14%-36.13%-17.54%57.13%19.52%-58.18%3.04%-7.88%-14.91%-2.55%-37.18%
EBT Growth (1y)
-617.77%32.62%-1,657.60%-8,042.81%75.58%67.91%75.53%16.02%36.67%54.79%-61.36%12.43%47.36%44.97%38.03%47.07%-33.36%-117.92%-29.33%-80.77%
EBT Growth (3y)
-738.44%-318.89%-258.81%-396.95%-705.43%-135.81%-332.02%-3.54%53.93%-90.73%-291.23%56.66%56.94%37.46%26.98%23.68%18.46%-8.95%5.73%
EBT Growth (5y)
-147.52%-187.99%-409.41%-147.48%-97.73%-103.03%-111.43%-164.72%-67.31%-107.48%4.87%34.86%-40.94%-124.71%
EBT Margin Growth (1y)
EBT Margin Growth (3y)
EBT Margin Growth (5y)
92.17M4,065.49M101.51M
EBT Margin (QoQ)
0.11M0.01M-0.02M
EBT (QoQ)
-31,401.05%17.93%48.34%39.03%5.54%-7.87%60.62%-109.29%28.77%22.99%-40.55%-13.58%57.18%19.50%-58.28%2.99%-7.89%-31.55%6.07%-35.59%
EPS (Basic) Growth (1y)
62.58%95.29%97.77%98.38%80.91%75.97%61.31%-12.08%45.88%63.28%9.76%36.93%80.01%-49.15%54.45%-30.56%-79.14%102.07%86.83%55.24%
EPS (Basic) Growth (3y)
-309.90%-71.70%-54.48%-103.83%-208.54%47.32%-72.82%66.19%83.92%80.19%77.45%72.56%49.14%45.82%2.64%42.13%26.23%62.17%28.30%
EPS (Basic) Growth (5y)
-22.87%-73.40%-115.97%-54.87%-25.14%-26.13%-21.97%-74.30%43.02%-35.71%57.51%14.87%78.43%63.25%
EPS (Basic) (QoQ)
89.07%9.49%67.41%49.71%-28.69%-13.92%47.52%-45.69%37.86%22.70%-28.97%-1.82%80.30%-476.63%60.61%-191.85%72.97%106.67%-350.47%-891.88%
EPS (Diluted) Growth (1y)
-380.00%50.78%70.45%98.38%81.17%75.97%61.31%-12.08%45.88%66.05%9.76%25.07%75.22%-93.99%15.56%-122.63%-262.91%104.16%74.06%6.03%
EPS (Diluted) Growth (3y)
-254.80%21.20%65.76%53.10%76.12%70.66%45.91%33.45%-23.20%21.34%26.57%41.75%-16.17%
EPS (Diluted) Growth (5y)
-135.98%15.14%14.91%53.14%50.92%
EPS (Diluted) (QoQ)
88.92%10.70%67.41%49.71%-28.69%-13.92%47.52%-45.69%37.86%28.54%-39.50%-20.97%79.45%-459.33%39.28%-218.96%66.50%106.42%-478.31%-1,055.24%
FCF Margin Growth (1y)
FCF Margin Growth (3y)
FCF Margin Growth (5y)
20.10M36.60M342.57M
FCF Margin (QoQ)
0.08M0.00M-0.04M
Free Cash Flow Growth (1y)FCF Growth (1y)
-963.52%-2,673.50%-244.38%-29.84%47.82%26.27%41.32%47.21%27.19%61.63%39.75%67.20%49.50%34.25%5.20%-57.22%-25.41%-76.93%-23.56%-120.95%
Free Cash Flow Growth (3y)FCF Growth (3y)
-226.73%-334.26%-393.07%-216.60%-330.38%-128.83%-59.28%-98.71%-6.78%39.19%42.32%42.92%30.54%35.19%22.74%23.58%10.97%-4.45%
Free Cash Flow Growth (5y)FCF Growth (5y)
-127.72%-98.48%-65.27%-69.96%-113.23%-51.59%-114.61%-43.94%-20.68%-55.62%-7.36%4.82%
Free Cash Flow (QoQ)FCF (QoQ)
-5.48%6.14%7.95%-42.48%57.61%-32.63%26.74%-28.18%41.54%30.11%-15.04%30.21%9.99%9.02%-65.87%-15.75%28.20%-28.35%-15.84%-106.98%
Gross Margin (QoQ)
-142.000.00M-394.00
Gross Profit (QoQ)
296.55%-18.43%-9.17%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-876.85%-174.90%-2.23%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
29.34%82.12%82.80%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
76.51%66.90%62.01%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-17.42%-558.93%80.24%62.07%52.65%-195.33%-33.18%
Net Cash Flow Growth (1y)NCF Growth (1y)
4,164.56%56.01%10.38%-13,712.17%-124.70%116.00%-128.17%90.18%3.68%-338.61%7.67%137.67%95.85%95.29%225.31%-555.61%1,795.63%402.46%-126.53%856.18%
Net Cash Flow Growth (3y)NCF Growth (3y)
1,008.53%-3,229.81%-226.03%124.34%-258.12%-27.22%-129.87%44.82%-31.75%71.39%-26.20%73.79%-31.19%44.76%38.87%-30.19%32.54%146.50%
Net Cash Flow Growth (5y)NCF Growth (5y)
32.06%-81.09%-223.40%323.83%-27.02%-0.88%119.39%-16.01%48.19%15.14%-15.95%180.44%
Net Cash Flow (QoQ)NCF (QoQ)
22,072.17%-144.23%211.69%-224.27%59.76%128.66%-296.57%56.68%-294.73%29.01%23.94%117.67%-143.52%19.44%2,122.17%-164.26%261.98%-85.63%-277.36%1,931.77%
Net Income Growth (1y)
-617.77%32.62%47.24%-5,867.52%75.48%66.32%59.01%-24.85%33.26%57.70%-18.43%9.41%73.23%-109.56%15.56%-122.63%-262.91%104.16%74.06%6.03%
Net Income Growth (3y)
-997.30%-318.97%-246.68%-437.68%-785.41%-51.34%-343.48%-5.51%54.21%36.49%-307.15%64.75%33.16%25.72%-36.05%13.44%26.76%36.22%-23.75%
Net Income Growth (5y)
-149.92%-224.18%-320.86%-193.52%-105.59%-115.86%-96.66%-261.26%-28.23%-180.58%-2.67%14.97%43.79%-169.13%
Net Income (QoQ)
-31,565.81%17.93%55.77%48.08%-30.09%-12.75%46.18%-58.15%30.46%28.54%-50.69%-20.97%79.45%-459.33%39.28%-218.96%66.50%106.42%-478.31%-1,055.24%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-617.77%32.62%47.24%97.45%75.48%66.32%59.01%-24.85%33.26%57.70%-18.43%9.41%73.23%-109.56%15.56%-122.63%-262.91%104.16%74.06%6.03%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-997.30%-318.97%-246.68%-437.68%-785.41%-51.34%-343.48%-5.51%54.21%36.49%69.31%64.75%33.16%25.72%-36.05%13.44%26.76%36.22%-23.75%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-149.92%-224.18%-320.86%-193.52%-105.59%-115.86%-96.66%-261.26%-28.23%-180.58%-2.67%14.97%43.79%42.95%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
86.44%17.93%55.77%48.08%-30.09%-12.75%46.18%-58.15%30.46%28.54%-50.69%-20.97%79.45%-459.33%39.28%-218.96%66.50%106.42%-478.31%-1,055.24%
Net Margin Growth (1y)
Net Margin Growth (3y)
Net Margin Growth (5y)
92.09M4,065.55M2,896.46M
Net Margin (QoQ)
0.25M-0.02M-0.14M
Operating Income Growth (1y)Op. Inc Growth (1y)
-290.33%-17.40%38.66%43.92%54.52%81.33%75.50%14.71%36.46%55.44%-55.91%13.90%47.97%44.80%35.86%47.09%-33.16%-90.13%-23.26%-74.40%
Operating Income Growth (3y)Op. Inc Growth (3y)
-350.22%-358.27%-279.43%-268.08%-272.73%-218.29%-331.09%-4.09%53.95%38.36%25.60%46.83%64.19%37.43%27.03%23.93%22.38%-7.22%7.38%
Operating Income Growth (5y)Op. Inc Growth (5y)
-136.21%-82.05%-97.60%-92.41%-105.62%-109.25%-75.16%-66.34%-100.31%-106.54%4.81%36.59%28.63%17.59%
Operating Income (QoQ)Op. Inc (QoQ)
-17.42%-163.57%70.35%38.87%4.78%-8.17%61.09%-112.84%29.07%24.14%-36.13%-17.54%57.13%19.52%-58.18%3.04%-7.88%-14.91%-2.55%-37.18%
Operating Margin Growth (1y)
Operating Margin Growth (3y)
Operating Margin Growth (5y)
91.95M4,065.06M2,909.62M
Operating Margin (QoQ)
0.12M0.00M-0.02M
Profit After Tax Growth (1y)PAT Growth (1y)
-623.76%32.61%-1,657.60%-8,042.81%75.58%67.91%75.53%16.02%36.67%54.79%-61.36%12.43%47.36%44.97%38.03%47.07%-33.36%-117.92%-29.33%-80.77%
Profit After Tax Growth (3y)PAT Growth (3y)
-997.30%-340.66%-283.51%-436.96%-771.27%-152.33%-323.15%-3.82%53.93%-90.73%-291.23%56.66%56.94%37.46%26.98%23.68%18.46%-8.95%5.73%
Profit After Tax Growth (5y)PAT Growth (5y)
-147.52%-201.77%-314.14%-190.25%-103.61%-111.19%-121.19%-177.50%-74.25%-104.99%4.71%34.86%-40.94%-124.71%
Profit After Tax (QoQ)PAT (QoQ)
-31,401.05%17.93%48.34%39.03%5.54%-7.87%60.62%-109.29%28.77%22.99%-40.55%-13.58%57.18%19.50%-58.28%2.99%-7.89%-31.55%6.07%-35.59%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
530.00%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-8.70%311.11%254.83%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.02M0.09M0.09M0.02M0.00M148.000.01M0.01M0.01M0.00M-0.03M-0.04M-0.03M-0.02M0.01M0.03M0.03M0.03M0.01M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.03M-0.02M-0.02M-0.02M-0.02M-0.01M-0.02M-0.01M0.09M0.07M-0.01M-0.02M-0.03M-0.01M0.00M0.01M0.01M-950.000.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.02M-0.04M-0.05M-0.04M-0.05M-0.03M-0.02M-0.01M0.10M0.10M0.03M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.02M0.01M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.00M-0.02M-0.01M0.01M0.00M0.02M0.01M0.01M0.00M0.00M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.05M-0.19M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.14M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.01M-0.06M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.03M-0.03M-0.03M-0.09M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.02M-788.000.00M-0.01M-0.05M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
269.97M929.70M1,858.03M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-270.12M-929.74M-1,858.06M91.95M4,065.06M2,909.62M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-659.62M-928.32M0.12M0.00M-0.02M
Revenue Growth (1y)
Revenue Growth (3y)
Revenue Growth (5y)
236.73%515.81%559.75%
Revenue (QoQ)
306.20%11.90%0.09%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
717.82%339.80%258.60%5.22%-65.32%-51.21%-47.90%-44.88%-35.12%-257.05%-65.18%-82.17%-72.36%103.66%-95.04%-30.93%-29.90%-97.73%1,158.33%107.46%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
98.54%79.88%22.54%-75.11%-13.35%-53.06%-60.38%-69.62%-79.20%-59.21%-49.91%-89.07%-39.88%-36.54%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-32.99%-6.44%-18.64%-69.13%-16.50%-31.74%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
66.31%0.64%-15.03%-26.01%-45.19%41.59%-9.27%-21.73%-35.48%-442.74%120.12%-59.92%0.00%-54.64%-72.73%458.33%1.49%-98.53%15,000.00%-7.95%
Tax Rate Growth (1y)
Tax Rate (QoQ)
Total Debt Growth (1y)
-72.37%-74.56%-82.91%985.05%173.10%-95.97%
Total Debt Growth (3y)
-10.18%-30.46%71.70%46.31%156.09%
Total Debt Growth (5y)
67.73%-7.33%20.26%0.39%38.77%43.73%42.82%
Total Debt (QoQ)
0.00%290.67%-57.49%436.21%21.85%-1.67%

NRX Pharmaceuticals Growth Metrics API

Pull NRX Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRXP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY